Air Products Teams-Up with Fox Chase Cancer Center: Cancer Screening and Risk Assessment Offered Free to Employees
PHILADELPHIA (July 25, 2000) -- Air Products and Chemicals, Inc. (NYSE:APD) of Allentown, Pa. and Fox Chase Cancer Center have teamed-up to increase cancer awareness with work site cancer screenings and a cancer risk assessments for employees. The Fox Chase Cancer Center screening program is funded by a $1.5 million dollar grant from the Pennsylvania Department of Health.
Air Products is one of six Pennsylvania employers taking advantage of the three-year grant. The customized program of prostate, breast and skin cancer screening at the work site is coordinated with Fox Chase's corporate screening program called CanPrevent: A Partnership at Work. The grant allows screening programs to be tailored to the employees based on confidential cancer risk surveys they provide. Employees will receive the screening and cancer education at their place of work. The convenience of workplace screening often leads to greater participation and enhanced opportunity for early detection of cancer.
"The purpose of this project is to learn if employers can help reduce the burden of cancer and lower medical costs by helping their employees detect cancer early when it is most curable," said Dr. Paul F. Engstrom, senior vice president for population studies at Fox Chase. "This type of partnership shows the dedication Air Products has for the health and well-being of its employees."
Participation by Air Products employees is totally voluntary, and all information will be strictly confidential. Claims information shared by the company with Fox Chase will be group data only; no information about individual employees will be submitted.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at: www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Diana Quattrone at 215-728-7784.